Clinical Trial Update: Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban [NA]

View source ↗

Summary

A terminated clinical trial evaluating changes in coagulation activity in patients with non-valvular atrial fibrillation being treated with apixaban.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-valvular Atrial Fibrillation

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Hopital Lariboisière | Conditions: Coagulation Disorder, Non Valvular Atrial Fibrillation | NA | Status: TERMINATED